Search Results

There are 10724 results for: content related to: Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder

  1. You have free access to this content
    Allopurinol for chronic gout

    Intervention Review

    The Cochrane Library

    Rakhi Seth, Alison SR Kydd, Rachelle Buchbinder, Claire Bombardier and Christopher J Edwards

    Published Online : 14 OCT 2014, DOI: 10.1002/14651858.CD006077.pub3

  2. You have free access to this content
    A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep

    The Journal of Physiology

    Volume 590, Issue 8, April 2012, Pages: 1825–1837, E. A. Herrera, A. D. Kane, J. A. Hansell, A. S. Thakor, B. J. Allison, Y. Niu and D. A. Giussani

    Version of Record online : 14 MAR 2012, DOI: 10.1113/jphysiol.2011.224576

  3. You have free access to this content
    Uricosuric medications for chronic gout

    Intervention Review

    The Cochrane Library

    Alison SR Kydd, Rakhi Seth, Rachelle Buchbinder, Christopher J Edwards and Claire Bombardier

    Published Online : 14 NOV 2014, DOI: 10.1002/14651858.CD010457.pub2

  4. Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study

    Bipolar Disorders

    Volume 14, Issue 2, March 2012, Pages: 206–210, Alexander Fan, Andrew Berg, Catherine Bresee, Lisa Hayley Glassman and Mark Hyman Rapaport

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1399-5618.2012.01001.x

  5. Febuxostat for treating chronic gout

    Intervention Review

    The Cochrane Library

    Jean H Tayar, Maria Angeles Lopez-Olivo and Maria E Suarez-Almazor

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD008653.pub2

  6. You have free access to this content
    Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy

    The Journal of Physiology

    Volume 592, Issue 3, 1 February 2014, Pages: 475–489, Andrew D. Kane, Jeremy A. Hansell, Emilio A. Herrera, Beth J. Allison, Youguo Niu, Kirsty L. Brain, Joepe J. Kaandorp, Jan B. Derks and Dino A. Giussani

    Version of Record online : 13 DEC 2013, DOI: 10.1113/jphysiol.2013.264275

  7. Allopurinol for chronic prostatitis

    Intervention Review

    The Cochrane Library

    Mary McNaughton Collins and Timothy J Wilt

    Published Online : 21 OCT 2002, DOI: 10.1002/14651858.CD001041

  8. You have free access to this content
    Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats

    British Journal of Pharmacology

    Volume 169, Issue 6, July 2013, Pages: 1352–1371, Wei Wang, Chuang Wang, Xiao-Qin Ding, Ying Pan, Ting-Ting Gu, Ming-Xing Wang, Yang-Liu Liu, Fu-Meng Wang, Shui-Juan Wang and Ling-Dong Kong

    Version of Record online : 21 JUN 2013, DOI: 10.1111/bph.12226

  9. Utilization of allopurinol in the Australian community

    Internal Medicine Journal

    Volume 38, Issue 6a, June 2008, Pages: 388–395, Y. Chung, 1,2 C. Y. Lu, 1,2, G. G. Graham, 1,2 A. Mant and 3,4 R. O. Day 1,2

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1445-5994.2008.01641.x

  10. Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate Level

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 3, September 2011, Pages: 392–398, L K Stamp, M L Barclay, J L O'Donnell, M Zhang, J Drake, C Frampton and P T Chapman

    Version of Record online : 27 JUL 2011, DOI: 10.1038/clpt.2011.113

  11. You have free access to this content
    Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

    Arthritis & Rheumatism

    Volume 63, Issue 2, February 2011, Pages: 412–421, Lisa K. Stamp, John L. O'Donnell, Mei Zhang, Jill James, Christopher Frampton, Murray L. Barclay and Peter T. Chapman

    Version of Record online : 28 JAN 2011, DOI: 10.1002/art.30119

  12. You have free access to this content
    Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study

    Arthritis Care & Research

    Volume 65, Issue 4, April 2013, Pages: 578–584, Seoyoung C. Kim, Craig Newcomb, David Margolis, Jason Roy and Sean Hennessy

    Version of Record online : 28 MAR 2013, DOI: 10.1002/acr.21817

  13. Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong

    British Journal of Dermatology

    Volume 167, Issue 1, July 2012, Pages: 44–49, M.L.S. Chiu, M. Hu, M.H.L. Ng, C.K. Yeung, J.C-Y. Chan, M.M. Chang, S.H. Cheng, L. Li and B. Tomlinson

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1365-2133.2012.10894.x

  14. You have free access to this content
    Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects

    British Journal of Clinical Pharmacology

    Volume 48, Issue 4, October 1999, Pages: 501–509, Turnheim, Krivanek and Oberbauer

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00041.x

  15. Understanding and improving the use of allopurinol in a teaching hospital

    Internal Medicine Journal

    Volume 45, Issue 4, April 2015, Pages: 383–390, R. C. Hmar, D. R. W. Kannangara, S. N. Ramasamy, M. T. Baysari, K. M. Williams and R. O. Day

    Version of Record online : 1 APR 2015, DOI: 10.1111/imj.12701

  16. You have free access to this content
    Inhibition of the development of leaf rust (Puccinia recondita) by treatment of wheat with allopurinol and production of a hypersensitive-like reaction in a compatible host

    Plant Pathology

    Volume 49, Issue 3, June 2000, Pages: 317–323, A. L. Ádám, A. A. Galal, K. Manninger and B. Barna

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-3059.2000.00455.x

  17. You have free access to this content
    Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol

    Arthritis & Rheumatism

    Volume 64, Issue 8, August 2012, Pages: 2529–2536, Lisa K. Stamp, William J. Taylor, Peter B. Jones, Jo L. Dockerty, Jill Drake, Christopher Frampton and Nicola Dalbeth

    Version of Record online : 27 JUL 2012, DOI: 10.1002/art.34488

  18. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

    International Journal of Rheumatic Diseases

    Volume 18, Issue 6, July 2015, Pages: 669–678, Shaoyong Xu, Xiangyang Liu, Jie Ming, Shenren Chen, Yangang Wang, Xiumei Liu, Hong Liu, Yongde Peng, Jianqin Wang, Jinying Lin, Haiwang Ji, Bin Liu, Ying Lu, Peng Liu, Yonghong Zhang and Qiuhe Ji

    Version of Record online : 27 MAY 2015, DOI: 10.1111/1756-185X.12648

  19. Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cells

    Journal of Applied Toxicology

    Volume 36, Issue 9, September 2016, Pages: 1120–1128, Akira Nakajima, Shingo Oda and Tsuyoshi Yokoi

    Version of Record online : 7 DEC 2015, DOI: 10.1002/jat.3272

  20. You have free access to this content
    Understanding the dose–response relationship of allopurinol: predicting the optimal dosage

    British Journal of Clinical Pharmacology

    Volume 76, Issue 6, December 2013, Pages: 932–938, Garry G. Graham, Diluk R. W. Kannangara, Sophie L. Stocker, Ian Portek, Kevin D. Pile, Praveen L. Indraratna, Indira Datta, Kenneth M. Williams and Richard O. Day

    Version of Record online : 20 NOV 2013, DOI: 10.1111/bcp.12126